Defitelio
Term · Oncology and biomedicine · MLC-T-ONC-002339
A drug used to treat hepatic veno-occlusive disease (a condition in which small veins in the liver are blocked) in adults and children who also have kidney or lung problems after receiving a stem cell transplant. Defitelio may affect the cells that line the inside of blood vessels and may help improve blood flow inside the liver. Also called defibrotide sodium.
| Identifier | MLC-T-ONC-002339 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | defibrotide sodium |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002339",
"term": "Defitelio",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat hepatic veno-occlusive disease (a condition in which small veins in the liver are blocked) in adults and children who also have kidney or lung problems after receiving a stem cell transplant. Defitelio may affect the cells that line the inside of blood vessels and may help improve blood flow inside the liver. Also called defibrotide sodium.",
"synonyms": [
"defibrotide sodium"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/defitelio/"
}
Record 5,776 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.